Allogenic ADSC cells in fibrin solution(Medical University Of Warsaw)

N/A

Report date: 2025/02/27 20:00:09

Base Information

Drug NameAllogenic ADSC cells in fibrin solution(Medical University Of Warsaw)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsDiabetic Foot

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedical University Of Warsaw

China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of Warsaw

Inactive CompaniesN/A

Active IndicationsDiabetic Foot

Inactive IndicationsN/A

Other Information

ATC CodeN/A